EXPERIENCE OF USE OF SPECIAL MOISTENING LOTION IN ATOPIC DERMATITIS

• Main Authors: E. G. Biryukova (Author), S. A. Efimova (Author), E. Yu. Varfolomeeva (Author), N. A. Fedorovskaya (Author), M. Yu. Astvatsaturova (Author), N. V. Visarova (Author), N. Yu. Savvateeva (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2014-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 1682-5527; 1682-5535; 10.15690/vsp.v13i1.929
• Keywords: children; atopic dermatitis; allergic reactions; basis skin care; Pediatrics; RJ1-570
• Source: Вопросы современной педиатрии, Vol 13, Iss 1, Pp 167-171 (2014)

Aim: to assess safety of moistening lotion in atopic dermatitis in children and their attitude toward basis skin care with the abovementioned drug. Patients and methods: 446 children aged from 14 days to 18 years old were included into the study, among them 222 (48%) girls and 244 (52%) boys; 271 (58,2%) of the patients were predisposed to allergic reactions, 158 (33,9%) were diagnosed with atopic dermatitis. All the patients and their parents were interviewed according to specially designed questionnaire, in which the main subjective sensations after the usage of the lotion (burning and dryness of the skin, hyperemia) were noticed. The evaluation wasperformed according to the three-point scale (0-2 points). Results: in assessment of subjective sensations after the usage of the lotion in the main group the absence of skin burning was observed in 443 (95,5%), absence of skin dryness - in 448 (96,1%) andabsence of hyperemia - in 457 (98,1%) of the children. In assessment of questionnaires of the children with atopic dermatitis absence of skin burning was found in 151 (95,6%), absence of skin dryness - in 152 (96,2%) and absence of hyperemia - in 155 (98,1%) of the patients. Moreover the drug showed high cosmetic acceptability in the both groups. Conclusions: high safety and cosmetic acceptability of the moistening lotion were confirmed both in the main group of children and in patients with atopic dermatitis.